Self-Reported Psychotic Disorders among Individuals with Substance Use Disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
Saved in:
| Title: | Self-Reported Psychotic Disorders among Individuals with Substance Use Disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. |
|---|---|
| Authors: | Lev‐Ran, Shaul (AUTHOR), Imtiaz, Sameer (AUTHOR), Le Foll, Bernard (AUTHOR) |
| Source: | American Journal on Addictions. 2012 Supplement 1, Vol. 21 Issue 6, p531-535. 5p. 1 Chart. |
| Subjects: | Substance abuse, Psychoses, Disease prevalence, Drug addiction, Drug abuse |
| Abstract: | Background and Objectives: Comorbidity of substance use disorders (SUDs) and psychotic disorders (PDs) presents many challenges in diagnosis and treatment. Most reports to-date focus on the prevalence of SUDs among clinical populations of patients with PDs, and there is a lack of data pertaining to rates of PDs among individuals with substance use and SUDs. Methods: We analyzed data on 43,093 respondents age 18 and above from the National Epidemiologic Survey on Alcohol and Related Conditions, a nationally representative US survey (Wave 1, 2001-2002). Cross-tabulations were used to derive prevalence estimates of PDs among individuals with 12-month substance use or SUDs across 10 categories of substances. Odds ratios (ORs) were derived from bivariate logistic regression analyses to examine the relationships between lifetime PDs and 12-month substance use or SUDs for the specific categories of substances. Results: Among individuals with 12-month substance use, prevalence of PDs was found to be elevated in 8 of 10 categories of substances, particularly among amphetamine (OR = 8.8) and cocaine (OR = 10.3) users compared to nonusers. Among individuals with SUDs, prevalence of PDs was elevated in 9 of 10 categories of substances compared to individuals without SUDs. Conclusions and Scientific Significance: Our findings on the increased rates of PDs among substance users and individuals with SUDs across a wide range of substances emphasize the importance of screening for PDs while treating patients with substance use and SUDs. This may allow for early intervention and adequate referral to appropriate settings. (Am J Addict 2012;21;531-535) [ABSTRACT FROM AUTHOR] |
| Copyright of American Journal on Addictions is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
